Cold Water Exposure and Immune Function Study
Effects of a 4 Week Cold Tub vs Cold Shower Immersion Intervention on Immune Function, Sleep Quality, Mental Health and Well-being, Gut Health, and Muscular Strength in Healthy, Physically Active Adults
1 other identifier
interventional
37
1 country
1
Brief Summary
The purpose of this clinical trial is to explore the effects of a 4 week cold-water immersion (CWI) intervention on measures of immune function, sleep quality, mental health and well-being, and muscular strength. The main questions it aims to answer are:
- Does a 4 week CWI intervention improve measures of immune function, sleep quality, mental health and well-being, and muscular strength?
- Are there any differences in these measures when comparing cold tubs versus cold showers? Researchers will compare chronic use of cold tubs to cold showers to see if cold water immersion may improve overall immune health and well-being. Participants will:
- Undergo 4 weeks of Cold Tub or Cold Shower interventions at a frequency of 3 times a week for 4 minutes, if placed in the CWI intervention groups
- Undergo testing measures at the two pre- and post- intervention time points, if placed in the healthy control group or the CWI intervention groups
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2024
CompletedStudy Start
First participant enrolled
October 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 10, 2026
November 1, 2025
1.3 years
October 10, 2024
March 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
C-Reactive Protein
Approximately 60mL of whole blood will be collected into serum separator tubes (Beckton Dickinson, East Rutherford, NJ, USA), allowed to clot for 30-min at room temperature, then centrifuged at 2000 RPM for 15 min. The serum will be pipetted into 1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, Germany) and immediately stored in a -80 °C freezer. Serum concentrations of CRP will be determined with a commercially available enzyme-linked immunosorbent assay (ALPCO Diagnostics, Salem, NH, USA). Microplates will be read with an ELx800 BioTek microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at the recommended wavelength of 450 nanometers.
Visit 1A (Week 1) and Visit 2A (Week 4): 15 minutes for blood draw. The assay itself takes 3 hours.
Interleukin-6 (IL-6)
Approximately 60mL of whole blood will be collected into serum separator tubes (Beckton Dickinson, East Rutherford, NJ, USA), allowed to clot for 30-min at room temperature, then centrifuged at 2000 RPM for 15 min. The serum will be pipetted into 1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, Germany) and immediately stored in a -80 °C freezer. Serum concentrations of IL-6 will be determined with a commercially available enzyme-linked immunosorbent assay (Thermo Fisher Scientific, Waltham, MA, USA). Microplates will be read with an ELx800 BioTek microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at the recommended wavelength of 450 nanometers.
Visit 1A (Week 1) and Visit 2A (Week 4): 15 minutes for blood draw. The assay itself takes 3 hours.
Secondary Outcomes (3)
Pittsburgh Sleep Quality Index (PSQI)
Visit 1A (Week 1) and 2A (Week 4): 10 minutes each
Depression Anxiety and Stress Scales (DASS-21)
Visit 1A (Week 1) and 2A (Week 4): 10 minutes each
Handgrip Dynamometry
Visit 1B (Week 1) and Visit 2B (Week 4): 10 minutes each
Other Outcomes (6)
Lean Body Mass
Visit 1A (Week 1) and Visit 2A (Week 4): 20 minutes each
Body Fat Percentage
Visit 1A (Week 1) and Visit 2A (Week 4): 20 minutes each
Immune Status Questionnaire (ISQ)
Visit 1A (Week 1): 5 minutes
- +3 more other outcomes
Study Arms (3)
Cold Tub Immersion Group (CI)
EXPERIMENTALParticipants will utilize the research cold tub (10 ºC, 4-minutes, 3 times a week), following a standardized protocol (see intervention description).
Cold Shower Group (CS)
EXPERIMENTALParticipants will utilize the research shower area (10 ºC, 4-minutes, 3 times a week), following a standardized protocol (see intervention description).
Control Group (CO)
OTHERParticipants will not undergo any cold tub or cold shower intervention.
Interventions
Once thermoneutral procedures are complete, participants in the CI group will be seated in the cold tub and submerged into the water (10º C). The sternal notch of each participant will be used as the anatomical marker to mark submersion point. Participants will sit with both arms outstretched underwater with their backs not touching the sides of the tub. Participants with a shorter stature will be provided an underwater cushion to meet the submersion requirements. The 4-minute timer will begin once confirmation of the participants submersion level and posture is determined. Once completed, the participant will be instructed to slowly exit the tub and allowed to dry and change as necessary.
Participants will be encouraged to maintain their current diet and exercise across the duration of the 4 week intervention. Participants will still be subjected to the pre- and post-intervention data collection session.
Once thermoneutral procedures are complete, participants in the CS group will be instructed to enter the research shower area. Within the shower area, the walls of the shower will be numbered from 1 to 4, with 1 defined as facing the faucet, 2 defined as 90° to the right of side 1, 3 defined as 180° from the faucet, and 4 defined as 270° to the right or 90° C to the left from side 1. Participants will be instructed to turn 90° to the right cycling through sides 1 to 4 and then back to 1 every 15 seconds prompted by the researcher. This will allow the participant to complete four full rotations in the shower during the 4-minute intervention time. The shower faucet is modified and oriented in a way where it only produces cold water (10º C) when turned on. Once completed, the participant will be instructed to slowly exit the shower and is allowed to dry and change as necessary
Eligibility Criteria
You may qualify if:
- Males and Females
- Aged 18-45
You may not qualify if:
- Currently practices CWI for \[\>3 times in the last month\]
- Pregnant or planning to become pregnant
- Chronic use of anti-inflammatory medication
- Prior history of chronic disease conditions:
- Cardiovascular Disease
- Diabetes
- Cancer
- Raynaud\'s Disease
- Severe and untreated anxiety or depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Northern Colorado - Gunter Hall
Greeley, Colorado, 80631, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 10, 2024
First Posted
October 31, 2024
Study Start
October 10, 2024
Primary Completion
February 1, 2026
Study Completion
March 1, 2026
Last Updated
March 10, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Oct 1, 2025 - Oct 1, 2028
- Access Criteria
- Individuals will email Laura.stewart@unco.edu with a request for study materials.
All study documents will be made available upon reasonable request (Laura.stewart@unco.edu).